Extended-spectrum beta-lactamases producing Klebsiella species isolated from several major hospitals in Iran

European Journal of Inflammation

Volumn 10, Issue 3, 2012, Pages 269-278

  Mohebi, R ^a   Ghafourian, S ^a,b   Sekawi, Z ^b   Neela, V ^b   Raftari, M ^b   Aboualigalehdari, E ^a   Sadeghifard, Nourkhoda ^a  

^a ILAM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

ESBLs; Iran; Klebsiella spp

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAMASE CTX M; BETA LACTAMASE SHV; BETA LACTAMASE TEM 1; CEFPODOXIME; CEFPODOXIME PLUS CLAVUNALIC ACID; CEFTAZIDIME; CEFTAZIDIME PLUS CLAVULANIC ACID; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM ISOLATION; ENZYME SYNTHESIS; GENOTYPE; HOSPITAL; IRAN; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; NONHUMAN; PHENOTYPE; PREVALENCE; SEASONAL VARIATION;

EID: 84873450342     PISSN: 1721727X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1721727X1201000303     Document Type: Article

References (21)

1. Korvick JA, Hackett AK, Yu VL, Muder RP. Klebsiella pneumonia in the modern era: clinicoradiographic correlations. South Med J 1991; 84:200-4.
2. Fang G, Fine MJ, Orloff JJ, Arisumi D, Yu VL, Kapoor W. New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore) 1998; 69:307-16.
3. Bradford PA, Cherubin CE, Idemyor V, Rasmussen BA, Bush K. Multiply resistant Klebsiella pneumoniae from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolates. Antimicrob Agents Chemother 1994; 38:761-6. (Pubitemid 24114015)
4. Pangon B, Bizet C, Bure A. In vivo selection of a cephamycin resistant, porin deficient mutant of Klebsiella pneumoniae producing a TEM-3-beta- lactamase. J Infect Dis 1989; 159:1005-6. (Pubitemid 19113092)
5. Sirot D, Chanal C, Henquell C, Labia R, Sirot J, Cluzel R. Clinical isolates of Escherichia coli producing multiple TEM mutants resistant to beta-lactamase inhibitors. J Antimicrob Chemother1994; 33:1117-26. (Pubitemid 24201955)
6. Villa L, Pezzella C, Tosini F, Visca P, Petrucca A, Carattoli A. Multiple-antibiotic resistance mediated by structurally related IncL/M plasmids carrying an extended spectrum beta-lactamase gene and class 1 integron. Antimicrob Agents Chemother 2000; 44:2911-14.
7. rd edition Philadelphia. Lippincott Williams and Wilkinson 1999.
8. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twentieth informational supplement, M100-S20. Wayne (PA): CLSI; 2010.
9. Paterson DL, Mulazimoglu L, Casellas JM. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Kelbsiella pneumoniae isolates causing bacteremia. Clin Infect Dis 2000; 30:473-78. (Pubitemid 30205291)
10. Shahcheraghi F, Moezi H, Feizabadi MM. Distribution of tern and SHV B-lactamase genes among Klebsiella pneumoniae strains isolated from patients in Tehran. Med Sci Monit 1007; 13:247-50.
11. Mansouri M, Ramazanzadeh R. Spread of extended spectrum beta-lactamases producing E.coli clinical isolates in Sanandaj hospital. J Biolog Sci 2009; 9:362-36.
12. Cheraghali AM, Nikfar S, Behmanesh Y, et al. Evaluation of availability, accessibility and prescribing pattern of medicines in the Islamic Republic of Iran. East Medit Health J 2004; 4:211-17.
13. Villanueva FD, Tupasi TE, Abiad HG, Baello BQ, Cardano RC. Extended-spectrum beta-lactamase Production among Escherichia coli and Klebsiella spp. at the Makati Medical Center: Tentative Solutions. Phil J Microbiol Infect Dis 2003; 32:103-8.
14. Kader AA, Kumar A. Prevalence and antimicrobial susceptibility of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general hospital. Ann Saudi Med 2005; 25:239-42. (Pubitemid 40959776)
15. Daoud Z, Hakime N. Prevalence and susceptibility patterns of extended-spectrum betalactamase-producing Escherichia coli and Klebsiella pneumoniae in a general university hospital in Beirut, Lebanon. Rev Esp Quimioterap 2003; 16:233-8. (Pubitemid 37011931)
16. Bouchillon SK, Johnson BM, Hoban DJ, et al. Determining incidence of extended spectrum β-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001-2002. Int J Antimicrob Agents 2004; 24:119-24. (Pubitemid 38993689)
17. Yaman A, Tasova Y, Kibar F, et al. Investigation of the antibiotic susceptibility patterns of pathogens causing nosocomial infections. Saudi Med J 2004; 25:1403-9. (Pubitemid 39429593)
18. Shehabi AA, Mahafzah A, Baadran I, Qadar FA, Dajani N. High incidence of Klebsiella pneumoniae clinical isolates to extended-spectrum β-lactam drugs in intensive care units. Diagn Microbiol Infect Dis 2000; 36:53-56. (Pubitemid 30085487)
19. Jones RN, Pfaller MA. Antimicrobial activity against strains of Escherichia coli and Klebsiella spp. with resistance phenotypes consistent with an extended-spectrum β-lactamase in Europe. Clin Microbiol Infect 2003; 9:708-12. (Pubitemid 36987045)
20. Huber TW, Thomas JS. Detection of resistance due to inducible β-lactamase in Enterobacter aerogenes and Enterobacter cloacae. J Clin Microbiol 1994; 32:2481-6. (Pubitemid 24284649)
21. Behrooozi A, Rahbar M, Yousefi JV. Frequency of extended spectrum beta-lactamase (ESBLs) producing Escherichia coli and Klebseilla pneumoniae isolated from urine in an Iranian 1000-bed tertiary care hospital. African J Microbiol Res 2009; 4:881-4.